Wells Fargo’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-260,300
| Closed | -$18.7M | – | 7356 |
|
|
2026
Q1 | $18.7M | Buy |
260,300
+160,300
| +160% | +$12.3M | ﹤0.01% | 1554 |
|
|
2025
Q4 | $7.94M | Buy |
100,000
+36,000
| +56% | +$2.84M | ﹤0.01% | 2250 |
|
|
2025
Q3 | $4.82M | Sell |
64,000
-136,000
| -68% | -$9.32M | ﹤0.01% | 2612 |
|
|
2025
Q2 | $13.8M | Sell |
200,000
-412,200
| -67% | -$27M | ﹤0.01% | 1670 |
|
|
2025
Q1 | $41.5M | Buy |
612,200
+512,200
| +512% | +$30.7M | 0.01% | 903 |
|
|
2024
Q4 | $4.49M | Buy |
+100,000
| New | +$5.61M | ﹤0.01% | 2533 |
|
|
2024
Q3 | – | Sell |
-320,000
| Closed | -$18.9M | – | 6944 |
|
|
2024
Q2 | $18.9M | Buy |
+320,000
| New | +$20M | ﹤0.01% | 1282 |
|
|
2023
Q4 | – | Sell |
-11,500
| Closed | -$803K | – | 7608 |
|
|
2023
Q3 | $803K | Buy |
+11,500
| New | +$815K | ﹤0.01% | 3481 |
|
|
2022
Q1 | – | Sell |
-203,000
| Closed | -$20.9M | – | 7158 |
|
|
2021
Q4 | $20.9M | Buy |
203,000
+3,000
| +2% | +$277K | 0.01% | 1306 |
|
|
2021
Q3 | $17M | Hold |
200,000
| – | – | ﹤0.01% | 1782 |
|
|
2021
Q2 | $16.7M | Hold |
200,000
| – | – | ﹤0.01% | 1813 |
|
|
2021
Q1 | $15M | Sell |
200,000
-1,224,700
| -86% | -$89.2M | ﹤0.01% | 1892 |
|
|
2020
Q4 | $1.4M | Buy |
1,424,700
+359,500
| +34% | +$23.4M | ﹤0.01% | 3765 |
|
|
2020
Q3 | $731K | Hold |
1,065,200
| – | – | ﹤0.01% | 4085 |
|
|
2020
Q2 | $1.54M | Buy |
1,065,200
+176,300
| +20% | +$11.1M | ﹤0.01% | 3469 |
|
|
2020
Q1 | $448K | Sell |
888,900
-323,100
| -27% | -$21.6M | ﹤0.01% | 4119 |
|
|
2019
Q4 | $3.5M | Buy |
1,212,000
+39,000
| +3% | +$2.74M | ﹤0.01% | 2877 |
|
|
2019
Q3 | $1.67M | Buy |
1,173,000
+820,600
| +233% | +$48.6M | ﹤0.01% | 3476 |
|
|
2019
Q2 | $561K | Buy |
352,400
+93,500
| +36% | +$5.04M | ﹤0.01% | 4293 |
|
|
2019
Q1 | $472K | Buy |
258,900
+58,900
| +29% | +$3.64M | ﹤0.01% | 4368 |
|
|
2018
Q4 | $1.14M | Hold |
200,000
| – | – | ﹤0.01% | 3735 |
|
|
2018
Q3 | $2.81M | Hold |
200,000
| – | – | ﹤0.01% | 3113 |
|
|
2018
Q2 | $1.18M | Buy |
+200,000
| New | +$13.2M | ﹤0.01% | 3884 |
|
|
2017
Q4 | – | Sell |
-1,000
| Closed | -$2K | – | 6365 |
|
|
2017
Q3 | $2K | Sell |
1,000
-200
| -17% | -$15.8K | ﹤0.01% | 6144 |
|
|
2017
Q2 | $3K | Sell |
1,200
-90,700
| -99% | -$7.16M | ﹤0.01% | 5998 |
|
|
2017
Q1 | $275K | Buy |
+91,900
| New | +$7.34M | ﹤0.01% | 4615 |
|
Other funds holding CVS
Wells Fargo's CVS Position: Q2 2026 in Review
Wells Fargo reduced its CVS Health (CVS) stake by 55% in Q2 2026, selling an estimated $395M and leaving 3,682,178 shares worth $381M. The position accounts for 0.06% of the portfolio, ranked #262.
Wells Fargo first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.11B in Q1 2016. 2,072 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Wells Fargo held 3,682,178 shares of CVS Health worth $381M as of Q2 2026.
- Wells Fargo sold 4,428,857 CVS Health shares in Q2 2026, an estimated $395M.
- CVS Health made up 0.06% of Wells Fargo's portfolio in Q2 2026, its #262 holding.
- Wells Fargo first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
- Wells Fargo's CVS Health position peaked at $1.11B in Q1 2016.
- 2,072 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.